Skip to main content

Advertisement

Table 1 Baseline patient characteristics (n = 36)

From: Capecitabine and oxaliplatin combined with bevacizumab are feasible for treating selected Japanese patients at least 75 years of age with metastatic colorectal cancer

Clinical characteristic Number of patients (%)
Sex
 Male 21 (58.3)
 Female 15 (41.7)
Age (years)  
 Median (range) 78 (75–86)
ECOG performance status
 0 30 (83.3)
 1 6 (16.7)
Primary sites
 Colon 24 (66.7)
 Rectum 12 (33.3)
Primary tumor resection
 Performed 23 (63.9)
 Not performed 13 (36.1)
Adjuvant chemotherapy  
 Performed 9 (25.0)
 Not performed 27 (75.0)
Appearance of metastasis
 Synchronous 19 (52.7)
 Metachronous 17 (47.3)
Metastatic sites
 Liver 21 (58.3)
 Lung 13 (36.1)
 Lymph nodes 14 (38.9)
 Peritoneum 2 (5.6)
 Other 2 (5.6)
Number of metastatic sites
 1 23 (63.9)
 2 11 (30.5)
 3 2 (5.6)
Creatinine clearance (mL/min)
 Median (range) 60.8 (32.6–84.6)
  1. ECOG Eastern Cooperative Oncology Group